Johnson & Johnson seeks to end decade-long talc litigation with $5.5 billion settlement
The Economic Times
Johnson & Johnson has agreed to a $5.5 billion settlement to resolve talc‑related cancer lawsuits, aiming to end a decade‑long litigation.Summary
Johnson & Johnson has reached a $5.5 billion settlement to resolve thousands of lawsuits alleging its talc products caused ovarian cancer. The deal follows three failed bankruptcy attempts and is designed to pay claims quickly—within two years—without binding future claimants. It requires acceptance by at least 95 % of the estimated 76,000 claims, and while it could finally end the current litigation, the company remains exposed to future lawsuits from people who develop cancer later.
(Source：The Economic Times)